Corrigendum to “Erythropoietin administration expands regulatory T cells in patients with autoimmune hepatitis” [J. Autoimmun. 119C (2021) 102629](S0896841121000378)(10.1016/j.jaut.2021.102629)

Elisa McEachern, Allison M. Carroll, Miguel Fribourg, Thomas D. Schiano, Susan Hartzell, Sofia Bin, Paolo Cravedi, Josh Levitsky*

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

Abstract

The authors would like to inform the readers that errors were made in the original article: There was an error in the abstract in regard to the dose of erythropoietin used in the study. Instead of “1000 IU”, it should read “10,000 IU”, which is what was used and reported in the manuscript. The authors wish to apologise for any inconvenience caused.

Original languageEnglish (US)
Article number102665
JournalJournal of Autoimmunity
Volume121
DOIs
StatePublished - Jul 2021

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Fingerprint

Dive into the research topics of 'Corrigendum to “Erythropoietin administration expands regulatory T cells in patients with autoimmune hepatitis” [J. Autoimmun. 119C (2021) 102629](S0896841121000378)(10.1016/j.jaut.2021.102629)'. Together they form a unique fingerprint.

Cite this